Myeloma Voices at ASH (https://www.myeloma.org/resources-support/imf-support-network/patient-blogs-ash)
Myeloma Voices at the American Society of Hematology (ASH) Meeting
For the last 20 years, the International Myeloma Foundation (IMF) has brought together a dedicated team of patients, care partners, and nurses to attend the American Society of Hematology (ASH) Annual Meeting, one of the world’s leading conferences for myeloma research. Through Myeloma Voices at ASH, our team helps bring the latest myeloma research and treatment advances directly to the people who need to hear about them most: the myeloma community.
Our mission is to make exciting scientific discoveries more accessible, understandable, and meaningful. While researchers and clinicians gather to share groundbreaking findings, our team is there to listen, learn, ask questions, and share what matters most from the patient and care partner perspective. Using vlogs, videos, social media posts, and other real-time updates, team members translate complex research into easier to understand concepts, helping patients, care partners, and families stay informed about developments that may shape the future of myeloma care.
Research is more powerful when everyone has access to it. You don’t have to attend ASH to be part of the excitement! Throughout the conference, our team will share highlights, reactions, and important takeaways from the latest research presentations. By combining scientific insights with the lived experiences of patients and care partners, Myeloma Voices at ASH helps bridge the gap between the research presented at a major scientific meeting and the people whose lives may be affected by those discoveries.
Follow the Team. Share the Excitement. Be Part of the Conversation.
We invite you to follow our Myeloma Voices at ASH team members on social media for timely updates, accessible explanations of emerging research, and personal perspectives from the conference. Like, comment on, and share their posts to help spread the word and connect even more people with the latest developments in myeloma research.
Follow the team, join the conversation, and experience ASH with us! Together, we can make sure the latest research reaches beyond the conference walls and into the hands of the myeloma community, bringing knowledge, connection, and hope to patients and care partners everywhere.
IMF Support Group Leaders have their fingers on the pulse of ASH 2024. Read their experiences during the 66th Annual ASH meeting.
(https://www.myeloma.org/what-is-multiple-myeloma)Myeloma is a cancer of the plasma cells in the bone marrow. The malignant plasma cells, or myeloma cells, accumulate in the bone marrow. These myeloma cells are abnormal plasma cells that divide uncontrollably, leading to the overproduction of dysfunctional antibodies and crowding out healthy blood cells.
Myeloma is a cancer of the plasma cells in the bone marrow. The malignant plasma cells, or myeloma cells, accumulate in the bone marrow. These myeloma cells are abnormal plasma cells that divide uncontrollably, leading to the overproduction of dysfunctional antibodies and crowding out healthy blood cells.
The content appearing on this page is not provided by the IMF. The IMF neither warrants nor guarantees the accuracy of such content. The forgoing notwithstanding, the content is not a substitute for advice and service provided by qualified and licensed medical professionals and should not be relied on with respect to any health matters. Any health-related information found herein is only made available as part of a general educational service.
